Baxter International Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
4.8
Bearish
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
BAX
Consensus analyst target of $22.12 is 29% above current price.
⚠ currently unprofitable (-10% margin).
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
HOLD
Target $22.12 (+28.5%)
13 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
BAX
UNH
—
Trailing P/E
27.9×
8.5×
Forward P/E
17.8×
-9.7%
Profit Margin
2.7%
34.6%
Gross Margin
18.8%
—
ROE
12.2%
2.9%
Revenue Growth
2.0%
—
Earnings Growth
0.7%
0.62
Beta
0.41
—
Price / Book
—
$8.9B
Market Cap
$334.9B
$16 – $33
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →